BetaEntity Annotation Prototype
← Back to diseases

Annotated abstract

Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept

bmjcr · 2025-10-26 · canonical JSON source

7 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

A 51-year-old female patient was diagnosed with primary biliary cholangitis (PBC) in 2012 and rheumafactor-positive, Anti-citrullinated protein antibodies (ACPA)-positive rheumatoid arthritis (RA) in 2013. The diagnosis of a PBC was confirmed by liver biopsy showing portal inflammatory infiltrates with non-suppurative inflammatory lesions of the biliary duct ( figure 1). PBC has been treated with ursodeoxycholic acid since 2012.